Omaveloxolone is a synthetic Nrf2 activator indicated for the treatment of Friedreich’s ataxia, a condition where it functions by reducing oxidative stress to help improve neurological function. This category… Read more
Omaveloxolone is a synthetic Nrf2 activator indicated for the treatment of Friedreich’s ataxia, a condition where it functions by reducing oxidative stress to help improve neurological function. This category encompasses Omaveloxolone reference standards, including the active pharmaceutical ingredient, its pharmacopeial and non-pharmacopeial impurities, and relevant metabolites essential for comprehensive analytical testing and quality control protocols. Laboratories utilize these high-quality reference materials for impurity profiling, method validation, and ensuring the accuracy of drug substance assays. Furthermore, stable isotope-labelled versions are available to facilitate precise pharmacokinetic studies and support mass spectrometry-based quantification, enabling researchers to track the drug and its degradation products with high specificity during complex bioanalytical procedures.